Skip to main content
ARDELYX, INC. logo

ARDELYX, INC. — Investor Relations & Filings

Ticker · ARDX ISIN · US0396971071 LEI · 549300F542QR4SXHCY32 US Manufacturing
Filings indexed 1,078 across all filing types
Latest filing 2018-07-20 Major Shareholding Noti…
Country US United States of America
Listing US ARDX

About ARDELYX, INC.

https://www.ardelyx.com/

Ardelyx, Inc. is a biopharmaceutical company that discovers, develops, and commercializes first-in-class medicines to address unmet medical needs. The company's primary therapeutic areas of focus are cardiorenal and gastrointestinal diseases. Its key commercial product is XPHOZAH® (tenapanor), a novel mechanism therapy for the control of serum phosphorus in adult patients with chronic kidney disease (CKD) on dialysis. Ardelyx also develops treatments for Irritable Bowel Syndrome with Constipation (IBS-C), aiming to advance patient care through its portfolio of innovative therapies.

Recent filings

Filing Released Lang Actions
ADAGE CAPITAL PARTNERS GP, L.L.C
Major Shareholding Notification
2018-07-20 English
FORM 3 SUBMISSION
Director's Dealing
2018-07-17 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is used for current reports on significant events. The content specifically announces the departure and transition of a senior executive (Chief Operating Officer) including severance and consulting arrangements. This matches the description of announcements related to changes in the company's board of directors or senior management. The document length is short and focused on management changes, not financial results or other report types. Therefore, the appropriate classification is Board/Management Information (MANG).
2018-07-09 English
FORM 4 SUBMISSION
Director's Dealing
2018-06-16 English
FORM 4
Director's Dealing
2018-06-16 English
FORM 4
Director's Dealing
2018-06-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.